Prot #OM-GRPR1-02: A Phase 1 Open-Label Dose Escal

Mahalingam, Devalingam (PD/PI)

Medicine, Hematology Oncology Division

Project: Research project

Status	Active
Effective start/end date	3/16/23 → 3/16/26

Funding

Medpace Clinical Research LLC (Prot #OM-GRPR1-02 // Prot #OM-GRPR1-02)
Orano Med, LLC (Prot #OM-GRPR1-02 // Prot #OM-GRPR1-02)